Psychopharmacology
In the present functional magnetic resonance imaging (MRI) study, we tested the effects of a direct pharmacological manipulation of DRD2 stimulation on intentional flexibility in a task-switching context, requiring switches between cognitive task rules and between response hands. In a double blind, counterbalanced design, participants received either a low dose of the DRD2 agonist bromocriptine or a placebo in two separate sessions.
Bromocriptine modulated the blood-oxygen-level-dependent (BOLD) signal during rule switching: rule-switching-related activity in the left posterior lateral frontal cortex and in the striatum was increased compared to placebo, at comparable performance levels.
Fronto-striatal connectivity under bromocriptine was slightly increased for rule switches compared to rule repetitions. Hand-switching-related activity, in contrast, was reduced under bromocriptine in sensorimotor regions. Our results provide converging evidence for
Introduction
Flexibility in perception, cognition and action is a prerequisite of managing everyday challenges. Recent theories on the neurochemical basis of individual differences in flexibility suggest a crucial role of the dopamine D2 receptor (DRD2) in modulating the flexible adaptation of behavior (Cools, 2011; Durstewitz and Seamans, 2008; Seamans and Yang, 2004) . In
